Warren Buffett Detailed Fundamental Analysis

Validea's fundamental report highlights ACCENTURE PLC (ACN), a large-cap computer services stock, as highly aligned with its Warren Buffett-inspired Patient Investor model, achieving an 85% score. This strong rating is attributed to ACN's long-term, predictable profitability, low debt, and reasonable valuation, as evidenced by its passing key fundamental tests including earnings predictability, free cash flow, and return on equity. The assessment suggests ACN offers a compelling profile for investors seeking stable, high-quality growth opportunities.

Analysis

According to a Validea fundamental report, Accenture PLC (ACN) scores highly at 85% on the 'Patient Investor' model, which is based on Warren Buffett's investment strategy. This score, approaching the 'strong interest' threshold of 90%, signals a significant alignment with the model's criteria for long-term, predictable profitability, low debt, and reasonable valuation. The positive assessment is substantiated by ACN passing multiple fundamental tests, including Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, and Free Cash Flow. This indicates robust financial health and efficient capital management. While the company's Share Repurchase activity received a 'Neutral' rating, its performance on key return metrics such as Initial Rate of Return and Expected Return was positive, reinforcing the view that the large-cap growth stock presents a favorable profile for quality-focused investors.

Key Decisions for Investors

• Given ACN's 85% score on the Buffett-inspired model and its passing marks on core fundamentals like profitability and low debt, investors focused on long-term, high-quality growth should view the stock as a compelling candidate.
• The positive ratings on 'Initial Rate of Return' and 'Expected Return' suggest that the stock is considered to be at a reasonable valuation, presenting a potentially attractive entry point for a company with strong fundamental backing.
• Investors should monitor ACN's capital allocation, particularly in light of the 'Neutral' rating on share repurchases, to ensure it continues to create shareholder value consistent with the model's principles.